Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.063 | 0.7 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.084 | 0.7 |